Corning Incorporated has announced its osteo-assay surface for bone cell assays.
This product is manufactured using a surface technology that mimics 'in vivo' bone and delivers high lot-to-lot consistency, enabling researchers to achieve more predictable and reproducible results, said Corning.
Corning's latest surface comes pre-applied in 24- and 96-well plate formats.
These ready-to-use multi-well plates also contain their own bar code for efficient automated tracking.
Corning's osteo-assay surface is designed to: maintain and grow bone cells for assays; provide reliable, uniform and consistent coating for direct assessment of bone cell function and differentiation; enable high-content analysis; and be used for solution-based quantitative assays.
'Through continuous interaction with our customer base, we understood the need for an alternative to the current methods of conducting bone cell assays that would allow for the study of functional activity between osteoclasts and osteoblasts,' said Dr Jeff Mooney, director commercial technology, Corning Life Sciences.
'Our osteo-assay surface provides researchers with the tools for conducting assays in a much more predictable manner to gain deeper insights and more advanced research results,' he added.
The Corning osteo-assay surface is currently available to US customers.
The company will be showcasing its osteo-assay surface in booth 1321 from 5-9 December at the American Society for Cell Biology's 49th Annual Meeting in San Diego, California.
